Lawless critical of judge shopping in Wall Street Journal article on WeWork bankruptcy

WeWork’s recent Chapter 11 filing in New Jersey is the seventh large bankruptcy filing in the state since the previous November, as corporations increasingly choose the state as the destination to restructure their debt. New Jersey’s share of large bankruptcies nationwide has risen to 5%, partly due to the stability provided by consistent judges in […]

Lawless and Brubaker sign letter urging abolition of Texas bankruptcy court panel

A dozen academics, including Professors Ralph Brubaker and Robert Lawless, are urging the United States Bankruptcy Court to abolish the two-judge panel on a south Texas bankruptcy court that has earned a reputation as a key venue for large bankruptcy cases. The letter from the legal scholars to Chief Judge Eduardo V. Rodriguez comes as […]

Lawless speaks to Philadelphia Inquirer about bankruptcy protection and student loans

When student loan payments resumed in October, an op-ed in the Philadelphia Inquirer proposed a solution to help debtors: Restore bankruptcy rights to student loans. To make his case, the author of the piece spoke to bankruptcy expert Professor Robert Lawless about the history of bankruptcy protection for student loans. Lawless explained that although federal […]

Lawless quoted in Reuters series on lasting effects of slavery

In their series on how the effects of slavery remain with us today, Reuters spoke to Professor Robert Lawless about the history of bankruptcy. The series, titled “Slavery’s Descendants” examines how slavery, the Jim Crow era, and racial discrimination put two different families (one white, one black) on very different economic paths. For part four, […]

Lawless quoted in article on Shelby County bankruptcies

In the past year, Shelby County, Tennessee, has a record of six bankruptcies per 1,000 residents, a rate that tops the nation. With none of the other 100 largest counties in the United States having more than four per 1,000, the difference is not particularly close, either. In their investigation of this phenomenon, MLK50: Justice […]

Brubaker submits amicus brief in Purdue Pharma case

In the case of Harrington v. Purdue Pharma, pending before the U.S. Supreme Court, Professor Ralph Brubaker has submitted an amicus brief arguing “Courts have no power to approve” the bankruptcy plan submitted by Purdue Pharma. Joined in writing the brief by fellow bankruptcy experts Professor Bruce Markell of Northwestern and Professor Jonathan Seymour of […]

Robbennolt and Winship author perception of settlement article for APA

Though the record-breaking settlement Dominion received in its settlement with Fox News is frequently characterized as a “win” by commentators, the statement from Fox with the settlement was not apologetic, did not acknowledge any responsibility, and was not a retraction. In a new article written for the American Psychological Association, Professors Jennifer Robbennolt and Verity […]

USA Today quotes Brubaker on Rite Aid bankruptcy

In an attempt to restructure its more than $3 billion in debt and confront lawsuits alleging the company filled opioid prescriptions unlawfully, Rite Aid is reportedly preparing to file bankruptcy. In an article examining the company’s motivations for doing so and the potential ramifications of their bankruptcy, USA Today quoted Professor Ralph Brubaker, an expert […]

Brubaker writes about Purdue Pharma’s appeal for Creditor Rights Coalition

As part of Creditor Rights Coalition’s “The Academics Speak Up” series, Professor Ralph Brubaker shared his thoughts on Purdue Pharma’s appeal to the U.S. Supreme Court in its bankruptcy proceedings. Brubaker made clear his feelings about the mechanisms by which Purdue was trying to discharge its debts in a direct and unsparing critique. “I am […]

Kaplan discusses Medicare’s announcement of impending prescription drug price negotiations on Chicago radio show

Professor Richard Kaplan was a guest on the September 1 episode of Joan Esposito’s radio show on WCPT Chicago. He discussed Medicare’s announcement of impending price negotiations for ten widely used prescription drugs pursuant to a provision in the Inflation Reduction Act of 2022.